Online citations, reference lists, and bibliographies.
← Back to Search

Differential Susceptibility Of Human Pleural And Peritoneal Mesothelial Cells To Asbestos Exposure

J. Dragon, Joyce K. Thompson, M. MacPherson, A. Shukla
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant mesothelioma (MM) is an aggressive cancer of mesothelial cells of pleural and peritoneal cavities. In 85% of cases both pleural and peritoneal MM is caused by asbestos exposure. Although both are asbestos‐induced cancers, the incidence of pleural MM is significantly higher (85%) than peritoneal MM (15%). It has been proposed that carcinogenesis is a result of asbestos‐induced inflammation but it is not clear what contributes to the differences observed between incidences of these two cancers. We hypothesize that the observed differences in incidences of pleural and peritoneal MM are the result of differences in the direct response of these cell types to asbestos rather than to differences mediated by the in vivo microenvironment. To test this hypothesis we characterized cellular responses to asbestos in a controlled environment. We found significantly greater changes in genome‐wide expression in response to asbestos exposure in pleural mesothelial cells as compared to peritoneal mesothelial cells. In particular, a greater response in many common genes (IL‐8, ATF3, CXCL2, CXCL3, IL‐6, GOS2) was seen in pleural mesothelial cells as compared to peritoneal mesothelial cells. Unique genes expressed in pleural mesothelial cells were mainly pro‐inflammatory (G‐CSF, IL‐1β, IL‐1α, GREM1) and have previously been shown to be involved in development of MM. Our results are consistent with the hypothesis that differences in incidences of pleural and peritoneal MM upon exposure to asbestos are the result of differences in mesothelial cell physiology that lead to differences in the inflammatory response, which leads to cancer. J. Cell. Biochem. 116: 1540–1552, 2015. © 2015 Wiley Periodicals, Inc.
This paper references
10.1002/jcb.24642
Malignant Mesothelioma: Development to Therapy
Joyce K. Thompson (2014)
10.1038/nprot.2012.016
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
C. Trapnell (2012)
10.1183/09031936.97.10010219
Physiology and pathophysiology of pleural fluid turnover.
Giuseppe Miserocchi (1997)
10.1165/AJRCMB.19.2.3111
Asbestos fibers and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells.
N. Choe (1998)
10.1200/EdBook_AM.2013.33.182
Peritoneal mesothelioma: the site of origin matters.
H. Kindler (2013)
10.1093/bioinformatics/btu170
Trimmomatic: a flexible trimmer for Illumina sequence data
A. Bolger (2014)
10.1007/s10495-006-9235-4
Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells
Y. Miura (2006)
10.1126/scisignal.3105cm1
Interleukin-1 (IL-1) Pathway
A. Weber (2010)
10.1080/01902140303788
SOLUBLE ICAM-1, MCP-1, AND MIP-2 PROTEIN SECRETION BY RAT PLEURAL MESOTHELIAL CELLS FOLLOWING EXPOSURE TO AMOSITE ASBESTOS
G. Hill (2003)
10.4137/CCRPM.S577
Immunological Changes in Mesothelioma Patients and Their Experimental Detection
M. Maeda (2008)
10.1245/s10434-013-2933-6
Intraperitoneal Cytokine Level in Patients with Peritoneal Surface Malignancies. A Study of the RENAPE (French Network for Rare Peritoneal Malignancies)
V. Vlaeminck-Guillem (2013)
10.1016/0923-2494(90)90059-8
Gamma delta T cells.
M. Lefranc (1990)
10.1111/J.2517-6161.1995.TB02031.X
Controlling the false discovery rate: a practical and powerful approach to multiple testing
Y. Benjamini (1995)
10.3892/IJO.25.1.173
Interleukin-1β and tumour necrosis factor-α promote the transformation of human immortalised mesothelial cells by erionite
Y. Wang (2004)
10.3109/08958378.2011.633942
Transcriptional activation of inflammasome components by Libby amphibole and the role of iron
J. Shannahan (2012)
10.1186/1743-8977-10-39
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Jedd M. Hillegass (2013)
10.1183/09031936.99.13351999
High pleural fluid hyaluronan concentrations in rheumatoid arthritis.
T. Söderblom (1999)
10.1165/rcmb.2008-0146OC
Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity.
A. Shukla (2009)
10.3109/1547691X.2013.847510
Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice
Aaron S Ferro (2014)
Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite.
Y. Wang (2004)
10.1152/ajplung.1999.277.2.L292
Asbestos exposure upregulates the adhesion of pleural leukocytes to pleural mesothelial cells via VCAM-1.
N. Choe (1999)
10.1111/J.1442-9993.2001.01070.PP.X
A new method for non-parametric multivariate analysis of variance in ecology
M. Anderson (2001)
10.1189/jlb.1012543
The role of inflammasome‐derived IL‐1 in driving IL‐17 responses
K. Mills (2013)
10.1038/SJ.KI.5002082
Role of mesothelial cell-derived granulocyte colony-stimulating factor in interleukin-17-induced neutrophil accumulation in the peritoneum.
J. Witowski (2007)
10.1016/j.mrgentox.2008.06.011
Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
M. Amati (2008)
10.1155/2013/436307
Interleukin-17: A Promoter in Colorectal Cancer Progression
Dang Wu (2013)
10.1186/1743-8977-11-2
In vitro determinants of asbestos fiber toxicity: effect on the relative toxicity of Libby amphibole in primary human airway epithelial cells
K. Duncan (2013)
Enrichment of Foxp 3 þ CD 4 regulatory T cells in migrated T cells to IL - 6 - and IL - 8 - expressing tumors through predominant induction of CXCR 1 by IL - 6
A Ferro (2010)
10.1007/s10147-004-0432-2
Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines
A. Yoshimoto (2004)
10.1158/1078-0432.CCR-12-3202
Extracellular Signal–Regulated Kinase 5: A Potential Therapeutic Target for Malignant Mesotheliomas
A. Shukla (2013)
10.1002/ijc.22006
Interleukin‐6 induces both cell growth and VEGF production in malignant mesotheliomas
Yasuo Adachi (2006)
10.1111/j.1749-6632.2010.05554.x
Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model
Jedd M. Hillegass (2010)
10.1016/j.taap.2014.01.018
Erionite induces production of autoantibodies and IL-17 in C57BL/6 mice.
Christian Nash Zebedeo (2014)
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.
M. Corradi (2013)
10.3109/07357907.2014.898156
Interleukin-8 and Interleukin-17 for Cancer
P. Zarogoulidis (2014)
10.1007/s10585-004-3150-2
Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma
B. Davidson (2004)
10.1006/JMCC.2000.1228
Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes.
T. Tanaka (2000)
Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos.
G. Brunetti (2003)
VEGF targeting in mesotheliomas using an interleukin-6 signal inhibitor based on adenovirus gene delivery.
Yasuo Adachi (2010)
10.1002/jso.21167
Malignant abdominal mesothelioma: Defining the role of surgery
D. Rodríguez (2009)
10.1016/S1357-2725(03)00242-5
The mesothelial cell.
S. Mutsaers (2004)
10.1016/j.ajpath.2012.12.028
New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.
B. Mossman (2013)
10.1016/S0272-6386(01)80131-1
Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: role of interleukin-1alpha.
S. Mandl-Weber (2001)
10.1371/journal.pone.0025391
LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells
M. Kanamori-Katayama (2011)
10.4049/jimmunol.1000225
Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6
S. Eikawa (2010)
10.1096/fj.05-4554fje
Transcriptional up‐regulation of MMPs 12 and 13 by asbestos occurs via a PKCδ‐dependent pathway in murine lung
A. Shukla (2006)
Transcriptional up-regulation of MMP12 andMMP13 by asbestos occurs via a PKCdelta-dependent pathway inmurine lung
A Shukla (2006)
10.1165/AJRCMB.10.3.8117443
Interleukin-1-mediated release of interleukin-8 by asbestos-stimulated human pleural mesothelial cells.
D. Griffith (1994)
10.1172/JCI115710
Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits.
A. Boylan (1992)



This paper is referenced by
10.1002/jat.3471
Profiling of the silica‐induced molecular events in lung epithelial cells using the RNA‐Seq approach
J. Chan (2017)
Exosomes And Their Role In Asbestos Exposure And Mesothelioma
Phillip B. Munson (2019)
10.1096/fj.201701291RR
Exosomes from asbestos‐exposed cells modulate gene expression in mesothelial cells
Phillip B. Munson (2018)
The role of inflammasomes in asbestos-induced mesothelial to fibroblastic transition
Joyce K. Thompson (2017)
10.1016/j.canep.2017.10.003
Differences between peritoneal and pleural mesothelioma in Lombardy, Italy.
C. Mensi (2017)
10.1080/10937404.2016.1195320
Pathology analysis for mesothelioma study in the United Kingdom: Current practice and historical development
B. Case (2016)
10.7176/jstr/5-6-02
Asbestos Exposure and Lung Carcinogenesis: Mechanism and Applications
P. E. Tokgun (2019)
10.1016/j.ajpath.2016.11.008
Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome.
Joyce K. Thompson (2017)
10.1186/s12989-016-0162-4
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases
M. Sayan (2016)
10.3892/ijo.2016.3335
KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma.
S. Cregan (2016)
KAT 5 ( Tip 60 ) is a potential therapeutic target in malignant pleural mesothelioma
S. Cregan ()
10.4999/uhod.182308
The Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Malignant Peritoneal Mesothelioma: A Tertiary Center Experience
H. Şahin (2018)
10.1111/1753-6405.12503
Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009
M. Soeberg (2016)
10.1002/1878-0261.12749
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
Kaire Ojasalu (2020)
10.1080/10937404.2016.1195323
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
10.1016/j.lfs.2019.116585
NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants.
M. Moloudizargari (2019)
10.1007/s11356-018-3693-4
Inflammatory and oxidative stress biomarkers at protein and molecular levels in workers occupationally exposed to crystalline silica
Caroline Peruzzi (2018)
10.1152/ajplung.00141.2020
Normal Mesothelial Cell Lines Newly Derived from Human Pleural Biopsy Explants.
Nathanael Pruett (2020)
10.1007/978-3-319-53560-9_7
Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases
Joyce K. Thompson (2017)
10.1007/978-1-4471-2825-0_15
Malignant Mesothelioma: Asbestos Exposure
R. Attanoos (2014)
10.15167/2421-4248/jpmh2019.60.4.1330
Health impact of exposure to asbestos in polluted area of Southern Italy
L. Vimercati (2019)
10.1007/978-3-030-16884-1_5
Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma
Elisabeth Digifico (2019)
10.3390/ht7030020
Genomics and Epigenetics of Malignant Mesothelioma
Adam P Sage (2018)
Semantic Scholar Logo Some data provided by SemanticScholar